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Background: The use of sequence independent methods combined with next generation sequencing for
identification purposes in clinical samples appears promising and exciting results have been achieved to
understand unexplained infections. One sequence independent method, Virus Discovery based on cDNA
Amplified Fragment Length Polymorphism (VIDISCA) is capable of identifying viruses that would have
remained unidentified in standard diagnostics or cell cultures.
Methods: VIDISCA is normally combined with next generation sequencing, however, we set up a simplified
VIDISCA which can be used in case next generation sequencing is not possible. Stool samples of 10 patients
with unexplained acute flaccid paralysis showing cytopathic effect in rhabdomyosarcoma cells and/or mouse
cells were used to test the efficiency of this method. To further characterize the viruses, VIDISCA-positive
samples were amplified and sequenced with gene specific primers.
Results: Simplified VIDISCA detected seven viruses (70%) and the proportion of eukaryotic viral sequences from
each sample ranged from 8.3 to 45.8%. Human enterovirus EV-B97, EV-B100, echovirus-9 and echovirus-21,
human parechovirus type-3, human astrovirus probably a type-3/5 recombinant, and tetnovirus-1 were identified.
Phylogenetic analysis based on the VP1 region demonstrated that the human enteroviruses are more divergent
isolates circulating in the community.
Conclusion: Our data support that a simplified VIDISCA protocol can efficiently identify unrecognized viruses grown in
cell culture with low cost, limited time without need of advanced technical expertise. Also complex data interpretation
is avoided thus the method can be used as a powerful diagnostic tool in limited resources. Redesigning the routine
diagnostics might lead to additional detection of previously undiagnosed viruses in clinical samples of patients.
Keywords: VIDISCA, cDNA-AFLP, Enterovirus, Human parechovirus, Human astrovirus, Tetnovirus, Sequence
independent method, Acute flaccid paralysis, PakistanBackground
The identification and characterization of viruses in clinical
samples is an essential component of community health
monitoring systems. A diverse range of conventional and
molecular based diagnostic assays are widely used to detect
these pathogens. Conventional assays like electron micros-
copy, cell culture and immunological methods have been* Correspondence: sohailz@live.com
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unless otherwise stated.successfully used for identification of viruses but in many
occasions these methods failed to detect the etiological
agent in clinical samples due to poor sensitivity and cross
reactivity. Therefore, molecular assays like polymerase
chain reaction (PCR) [1], universal primer PCR [2-4], pan
viral microarray, cDNA library immunoscreening [5], sub-
stitution hybridization [6-8] have been used for detection
of unknown viruses, but these methods were not always
proven useful due to increased diversity of viral genome,
low viral loads in clinical samples and presence of a variety
of organisms in a single specimen. Therefore, there is al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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tools to deal with such problems.
In recent years the technological innovations involving
sequence independent amplification techniques and next
generation sequencing (NGS) have boosted virus discov-
ery and these NGS-based techniques are becoming the
standard for the discovery of viral pathogens in clinical
samples. Among these innovations, sequence independent
methods have been used efficiently to identify unknown
viruses in diagnostic virology. One of these methods, Virus
Discovery based on cDNA Amplified Fragment Length
Polymorphism (VIDISCA), has proven to be a successful
tool for identification of unknown viruses [9]. This method
is capable of detecting both DNA and RNA viruses without
prior knowledge of the viral family, and is based on restric-
tion enzyme digestion. Nowadays VIDISCA is combined
with next generation sequencing, but at the time it was
developed (2004), it has been successfully used to discover
novel viruses from cell culture like human coronavirus
NL63 (HCoV-NL63) [10], human parechovirus type 5 and
6 [11] and human parechovirus type 1 variant [12]. Stand-
ard VIDISCA uses a two step PCR amplification protocol
with a complex second selective amplification round, and
subsequent isolation of PCR fragments which are not in
uninfected cultures. This last amplification step is com-
plex and labor intensive, but needed to distinguish back-
ground ribosomal RNA PCR fragments from the viral
PCR products. However, pre-treatment of samples prior
to VIDISCA has significantly been optimized and ampli-
fication of ribosomal RNA has diminished dramatically
[13]. Therefore, a simplified VIDISCA protocol was de-
veloped, which lacks the last amplification round, and
evaluated using viruses that were cultured from stool
samples of acute flaccid paralysis children, and which
had remained unrecognized on both cell culture and
enterovirus specific real-time PCR.
Results
Virus discovery techniques are often a combination of
unbiased amplification and high throughput sequencing.
However, high throughput sequencing is almost impos-
sible in developing countries like Pakistan because its
cost is prohibitive. Therefore, we used a simple and cheap
alternative virus discovery tool, which is a combination of
a short virus culture together with a simplified version of
VIDISCA (an overview of the adaptations is shown in
Additional file 1: Table S1). Ten supernatants from
CPE-showing cultures of stool from patients with Acute
Flaccid Paralysis were tested (patient characteristics are
shown in Table 1). The virus cultures had been examined
by the standard diagnostics but remained negative (data
not shown). All of the study samples yielded PCR frag-
ments on 3% metaphor gel (Figure 1). Of each sample the
PCR products which were present in the samples but notin the cell culture control were cut from gel and cloned
in E.coli. Twelve to 24 cloned products were Sanger se-
quenced. A significant amount of nucleotide sequences
showed identity to known viruses in 7 samples (70%).
These viral sequences matched with members belonging to
different families e.g. Picornaviridae, Astroviridae (Table 2).
The proportion of eukaryotic viral sequences in each sam-
ple varied and ranged from 8.3% to 45.8%. Four human
enteroviruses were identified (serotypes EV-B97, EV-B100,
echovirus (E)-9 and E-21), human parechovirus type 3
(HPeV-3), tetnovirus-1 (TNV-1), and one human astro-
virus (several fragments of which some with identity
to type 3 (HAstV-3) and other fragments - at different lo-
cations of the genome - showing identity with human
astrovirus type 5 (HAstV-5). To further characterize the
viruses, the 7 VIDISCA-positive samples were amplified
and sequenced with gene specific primers. For the human
enteroviruses and the parechovirus the VP1 gene was
used, and the ORF1a and ORF2 genes were used for the
astrovirus.
Phylogenetic analyses of the VP1 gene were performed
to investigate the genetic relationships between the human
enterovirus strains from this study (PAK-NIH VS458A,
VS870, VS1661A and VS4515) and the enterovirus sero-
types in GenBank (Figure 2). The nucleotide identity be-
tween the study strains and their reference prototypes
ranged from 78.7% to 91.9% and within each serotype
from 79.2% to 98.8%. The nucleotide sequence identity
between PAK-NIH-VS1661A and the closest relative
echovirus 21 (Farina;AF081334) was only 78.7% and
thus this isolate represents a separate genotype, match-
ing most closely with strains from India, China and
Sweden (Genbank accession numbers are shown in
Figure 2). Phylogenetic analysis of the VP1 coding region
of HPeV strains available in GenBank and our study isolate
(PAK-NIH-VS1123) showed clustering with HPeV type 3
strain 651689 (FJ373153) isolated in Amsterdam, the
Netherlands (Figure 3). The strains had 92% nucleotide
identity and 99% amino acid identity with each other.
The ORF1a and ORF2 sequences of astrovirus PAK-
NIH-VS908 were aligned and compared with sequences
from GenBank including those who gave the largest
similarity in blast alignments. The genetic analysis in
ORF1a gene (Serine protease) showed that the study
isolate belongs to human astrovirus type 5 representing
94.5% nucleotide identity and 99% amino acid identity
with HAstV isolate DL030 (JQ403108). On the other
hand, genetic analysis in ORF2 gene (capsid protein)
showed that PAK-NIH-VS908 shared 99.7% nucleotide and
100% amino acid similarities with HAstV type 3 isolate
IDH2211 (AB54844), a finding which matches with the
results from VIDISCA and we conclude that the astro-
virus is a recombinant, with a recombination site between
ORF1a and ORF2. Phylogenetic trees were constructed
Table 1 Clinical and demographical data of children with acute flaccid paralysis in this study
S. NO. Sample ID Collection year Male (M)/Female (F) Age (months) Asymmetrical paralysis Fever
1 PAK_NIH_VS1661A 2010 M 25 Yes Yes
2 PAK_NIH_VS458A 2009 M 09 Yes Yes
3 PAK_NIH_VS870 2009 M 14 Yes Yes
4 PAK_NIH_VS4515A 2010 M 48 Yes Yes
5 PAK_NIH_VS908 2008 F 06 No Yes
6 PAK_NIH_VS926 2008 M NA Yes Yes
7 PAK_NIH_VS1123 2009 F 51 Yes No
8 PAK_NIH_VS242 2009 M 25 No Yes
9 PAK_NIH_VS3099 2009 F 70 No No
10 PAK_NIH_VS7113 2008 F 11 Yes No
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that PAK-NIH-VS908 has different grouping patterns in
relation to the reference HAstV prototypes (Figure 3),
confirming that the isolate is most probably a recombin-
ant (Figure 3).
The partial nucleotide sequence of PAK-NIH-VS926
(222-nucleotides) showed most identity with tetnovirus-1
strain (HM480375) isolated from an AFP patient in
Afghanistan (Figure 3). Pairwise distance calculation
showed 82.9% nucleotide identity with its closest match
and therefore PAK-NIH-VS926 probably presents a di-
vergent isolate within this group.
Discussion
In recent years, sequence independent PCR approaches
have revolutionized identification of unknown and novel
viruses either alone or in combination with conventional
methods. In this study a simplified version of VIDISCA
was used to detect human enteroviruses, a human pare-
chovirus type 3, a human astrovirus, and a tetnovirus-1 in
cell culture. Our data show that a wide range of distinctFigure 1 VIDISCA PCR fragments visualized on a 3% metaphor gel wh
40 cycles. Lane 1: control supernatant from uninfected RD cells; Lane 2–6:
PCR product of cultured viruses harvested from RD cells; Lane 12: 25 baseviruses that remained unrevealed through routine assays
can be identified in a relatively short amount of time with
an easy to use method. The VIDISCA method is based on
cDNA-AFLP and one characteristic of this method is that
it uses a double PCR strategy, with in the second round
of amplification selective primers (selective PCR-round).
These selective primers are extended at the 3′ site with
one or two nucleotides, and in the selective PCR various
combinations of primers are used in order to amplify
everything which was amplified in the first PCR. This
selective PCR step is a complex and laborious step in
VIDISCA, but was needed previously to distinguish viral
PCR fragments from ribosomal RNA amplicons. However,
an improved purification and reverse transcription step
which strongly diminishes ribosomal RNA amplification
has recently been published, and therefore the laborious
selective amplification step might not be needed [13].
Here, we show that in the majority of virus cultures
simplified-VIDISCA can quickly reveal the infecting agent.
We previously published that VIDISCA in its original set-
ting can identify a virus in picornavirus-cultures in >90%ich were generated after amplification in a single round PCR of
PCR product of cultured viruses harvested from L20B cells; Lane 7–11:
pair molecular weight marker.
Table 2 Identification of viruses in AFP patients by VIDISCA
S. NO. Sample ID No of colonies sequenced No of viral sequences % of viral sequences VIDISCA-result
1 PAK_NIH_VS1661A 24 2 8.3 Echovirus −21
2 PAK_NIH_VS458A 24 7 29.1 Enteovirus-B97
3 PAK_NIH_VS870 24 8 33.3 Echovirus-9
4 PAK_NIH_VS4515A 24 10 41.6 Enterovirus-B100
5 PAK_NIH_VS908 24 11 45.8 Human astrovirus type 3 and type 5
6 PAK_NIH_VS926 12 1 8.3 Tetnovirus-1
7 PAK_NIH_VS1123 12 1 8.3 Human Parechvirus type 3
8 PAK_NIH_VS242 12 0 0 -
9 PAK_NIH_VS3099 12 0 0 -
10 PAK_NIH_VS7113 24 0 0 -
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here is largely comparable, but we must mention here that
we did not compare the sensitivity of traditional VIDISCA
and simplified VIDISCA directly in our study.
The possible failure of screening of study samples via
routine assays may be due to increased genetic diversity
at PCR priming annealing sites [14,15]. Seven viruses
(EV-B97, EV-B100, E-9 and E-21, HPeV-3, HAstV-3/5
and TNV-1) were identified which originate from stool
samples of AFP patients. The clinical significance of these
viruses has great impact on public health and constitutes a
health risk for the community. All isolated enteroviruses
belong to enterovirus B species containing the most
frequently isolated serotypes that more commonly cause
meningitis, myocarditis and neurological disorders [16-20].
Some enteroviruses cause severe and potentially life-
threatening illness and there is currently no antiviral
treatment available for enterovirus infection [19]. Phylo-
genetic clustering of our study isolates reveals that the
enteroviruses are related to the circulating strains which
have been reported in neighboring countries: India and
Bangladesh. Our analysis also showed that the nucleotide
sequence of echovirus 21 isolate (PAK-NIH VS1661A) has
low nucleotide identity (78.7%) with prototype Farina
strain (AF081334) that fulfils the criterion for a genotype
[21] and therefore we suggested that it is a separate geno-
type of E-21 circulating in the area. Importantly, the emer-
gence of new genetic lineages of enteroviruses in the
community is an alarming situation for Pakistan where
there is no enterovirus surveillance system. Aside from
poliovirus, which is the target pathogen of the polio eradi-
cation strategy, the non-polio enterovirus detection in the
laboratory is only a “part-outcome” of AFP surveillance. In
Pakistan, despite the significant number of isolated non-
polio enteroviruses, limited information is available with
regard to its incidence, diversity and circulation pattern.
Consequently, it is the right time to prepare for future
tasks and to give attention towards non polio virusescausing AFP which is an equal cause of concern while we
are approaching towards the polio eradication era.
Similarly, HPeVs are known to cause a variety of clinical
symptoms similar to enteroviruses like gastroenteritis and
occasionally flaccid paralysis and encephalitis [22,23] par-
ticularly in infants, and they are considered a major cause
of infant mortality worldwide. HPeV types 1, 5, 6, 7 and
12 were isolated from stool samples of non polio AFP pa-
tients <3 years of age [24-26]. In this study we identified
HPeV-3 in a seven months old paralytic infant having
fever. Our findings was in agreement with previous studies
in which HPeV-3 was isolated from children aged less
than three years having transient paralysis and sepsis like
illness [22,27].
Astrovirus is one of the known causes of acute gastro-
enteritis in humans, mostly in young children. It has been
isolated earlier from stool of an AFP patient [28]. In this
study, an astrovirus was isolated from a six months old
child. A follow up examination after 60 days indicated the
complete recovery of patient from paralysis. Phylogenetic
analyses of PAK-NIH-VS908 based on ORF1a and ORF2
genes clustered this isolate in two different genotypes;
HAstV-5 and HAstV-3. This genotype discrepancy among
phylogenetic analysis of both genes most likely represents
a possible recombination event in the evolution of
HAstVs. Recombination is a normal phenomenon among
these viruses [29-32].
PAK-NIH-VS926 is the most divergent strain of the type
1 tetnoviruses. Tetnovirus-1 is an RNA virus containing
two large ORFs encoding structural and non-structural
proteins. The non-structural protein of tetnovirus-1 con-
tains an RNA dependent RNA polymerase (RdRp) and a
cysteine-like protease domain. The genomic organization
of TNV-1 is more closely related to the viruses classified
in the family Tetraviridae. Tetnoviruses are closely related
to nodaviruses within the RdRp protein. The host of
nodaviruses is fish and arthropods, including insects.
Tetnovirus-1 and −2 have been isolated earlier from
Figure 2 Phylogenetic analyses based on VP1 nucleotide sequences of PAK NIH isolates and representative sequences of enterovirus
serotypes retrieved from GenBank. The isolates characterized by VIDISCA are represented by a ‘●’ taxon marker. Prototype strains are labeled
with taxon markers ‘▲’. The tree was constructed using neighbor-joining (NJ) method and Kimura 2-Parameter (K2P) model in MEGA 4.0 and
evaluated with 1000 bootstrap pseudoreplicates. Bootstrap values greater than 50 are indicated at the respective nodes and the scale bar
represents the evolutionary distance.
Shaukat et al. Virology Journal 2014, 11:146 Page 5 of 8
http://www.virologyj.com/content/11/1/146stool samples of AFP children of Afghanistan [33]. Future
studies are needed to identify the origins of these viruses
and to clarify their in vitro replication and pathogenic po-
tential in AFP children.
Nowadays sequence independent methods followed
by high throughput sequencing [34-36] are becoming
more promising means for detection of novel pathogens.However, highly developed technical skills, involvement of
bioinformatics’ support, adequate computing resources,
advanced data interpretation and high costs are major
barriers for their use in developing and resource-limited
countries, which are exactly those regions where out-
breaks of new pathogens are likely to occur [28,37-39].
Therefore, we consider the adaptation of VIDISCA a
Figure 3 Phylogenetic analyses of A) Human astrovirus ORF2 B) Human astrovirus ORF1a C) Human Parechovirus VP1 and D)
Tetnovirus unknown gene. The representative sequences of the serotypes are retrieved from GenBank (accession numbers are included in the
virus names). The isolates from this study are represented by a ‘●’ taxon marker. The closely related strains are labeled with taxon markers ‘▲’.
The tree was constructed using neighbor-joining (NJ) method and Kimura 2-Parameter (K2P) model in MEGA 4.0 and evaluated with 1000
bootstrap pseudoreplicates. Bootstrap values greater than 50 are indicated at the respective nodes and the scale bar represents the
evolutionary distance.
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and it can be successfully completed in a limited time
without technical difficulties. This assay is applicable
independently in any laboratory having only PCR and
sequencing facilities and can be reproduced easily from
the literature.
Conclusion
Our data support that VIDISCA may be of great util-
ity for the identification of viruses that escaped con-
ventional diagnostics. Furthermore, avoiding the cost,
time, labor and use of specialized equipments made it
an efficient and powerful diagnostic tool for resource
poor countries. Finally, our findings also provide con-
fidence to improve and redesign the routine diagnos-
tic assays which might lead to additional detection of
previously undiagnosed viruses in clinical samples of
patients.Methods
Patient samples and virus culture
A total of ten stool samples from AFP children aged less
than 15 years were selected from the sample bank of acute
flaccid paralysis patients at the Virology department,
National Institute of Health, Pakistan (Table 1). All these
samples showed a cytopathic effect (CPE) in rhabdomya-
sarcoma cells (RD) and mouse cells that have receptors
for human polioviruses (L20B) and found negative for en-
terovirus by real-time reverse transcription PCR targeting
the 5′UTR of the genome [40]. Cell culture controls each
for L20B and RD cells were included
Ethics statement
This study was approved by the Internal Review Board of
National Institute of Health, Pakistan. Written informed
consent was obtained from parents (or guardians) of
participating patients.
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The pretreatment of samples was used prior to VIDISCA
to reduce background nucleic acids. Samples were centri-
fuged (10.000 g) and supernatant was digested with Trubo
DNase (Ambion). Extraction and isolation of nucleic acids
was performed according to the protocol of Boom et al.
[41]. Reverse transcription was performed using random
hexameres, designed such that they do not anneal to ribo-
somal RNA as described by Endoh et al. [42], and Klenow
polymerase was used for second strand synthesis (New
England Biolabs). The double stranded DNA was subse-
quently digested and annealed to adaptors as described by
de Vries et al. [13], followed by PCR, only one round of
40 cycles, which is different from the protocol as de-
scribed [10] A cookbook version of the method is pre-
sented as Additional file 2: (Doc. S2). Sequences were
trimmed from raw sequencing data using Sequencher
programe version 4.9 (Gene Codes corporation) and
analyzed online (http://www.ncbi.nlm.nih.gov/BLAST). The
blastn and blastx algorithms were used to identify se-
quences with similarity to known viruses in GenBank
and those sequences identified as viral were further
classified into viral families based on the taxonomy of
the best hit.
Typing and viral characterization
All samples with sequence identity to known viruses
were characterized with gene specific PCRs to confirm
the presence of the pathogen in the samples. The
capsid-encoding VP1 gene of human enteroviruses and
human parechovirus type 1 was amplified by using primers
490/492, 491/493 [43] and VP1-parEchoF1/VP1-parEchoR1
[44] respectively. Similarly ORF1a and ORF2 genes of
human astrovirus were amplified by using primers
Mon269/Mon270 and Mon340/Mon348 [29] respectively.
Amplified DNA products were visualized on 2% agarose
gel and sequenced with the same primers as used in PCR.
Phylogenetic analyses were conducted using MEGA
(Molecular Evolutionary Genetic Analysis) version 4.0
[45] and p distances (nucleotide and amino acids) were
computed. Trees were constructed by Neighbor Joining
(NJ) method using Kimura 2-parameter (K2P) model for
nucleotide sequences [46] and bootstrap values with 1000
pseudo replicate data sets were estimated. Sequences from
this study were submitted to GenBank with the Accession
numbers KF453625-KF453632.Additional files
Additional file 1: Table S1. An overview of the adaptations in the
VIDISCA protocol.
Additional file 2: Doc. S2. A cookbook version of the simplified
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